Risk and predictors of severity and mortality in patients with type 2 diabetes and COVID-19 in Dubai.

Autor: Alawadi F; Department of Endocrinology, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Bashier A; Department of Endocrinology, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Bin Hussain AA; Department of Endocrinology, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Al-Hashmi N; Department of Endocrinology, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Bachet FAT; Department of Endocrinology, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Hassanein MMA; Department of Endocrinology, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Zidan MA; Department of Medical Education and Research, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Soued R; Department of Radiology, Mediclinic City Hospital, Dubai, United Arab Emirates., Khamis AH; College of Medicine, Mohamed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Mukhopadhyay D; College of Medicine, Mohamed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Abdul F; College of Medicine, Mohamed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Osama A; College of Medicine, Mohamed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Sulaiman F; College of Medicine, Mohamed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Farooqi MH; Dubai Diabetes Center, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Bayoumi RAL; Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. riad.bayoumi@mbru.ac.ae.

Publikováno v: World journal of diabetes [World J Diabetes] 2023 Aug 15; Vol. 14 (8), pp. 1259-1270.